Clinical outcomes in patients with lung cancer admitted to intensive care units
| Autor: | Yoonki Hong, Ji Young Hong, Woo Jin Kim, Jinkyeong Park |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Critically ill General Medicine 030204 cardiovascular system & hematology medicine.disease Intensive care unit law.invention 03 medical and health sciences 0302 clinical medicine law 030220 oncology & carcinogenesis Internal medicine Intensive care medicine Infection control National database In patient Original Article business Lung cancer Cancer staging |
| Zdroj: | Ann Transl Med |
| ISSN: | 2305-5839 |
| Popis: | BACKGROUND: Recent advances in critical care and infection control have led to improved intensive care unit (ICU) survival rates. However, controversy exists regarding the benefits of ICU treatment for patients with lung cancer. In this study, we evaluated the clinical outcomes of patients from the Korean national database, who had been diagnosed with lung cancer and had received ICU treatment. METHODS: We investigated patients in Korea who had been newly diagnosed with lung cancer between January 1, 2008 and December 31, 2010. We classified these critically ill patients with lung cancer according to their lung cancer treatment pathways, with a specific focus on those who had undergone ICU treatment. RESULTS: We found that 31.3% of patients newly diagnosed with lung cancer had been admitted to the ICU for any reason, and 18.5% of patients with lung cancer were admitted to the ICU for reasons other than postoperative surgical lung cancer resection. The ICU mortality rate was 2.9% in patients admitted to the ICU for postoperative care and 47.5% in patients admitted for other reasons. Clinical cancer staging (HR, 7.02; 95% CI, 5.82–8.48; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|